Second shot at aneurysm fix: new pilot study launches
NCT ID NCT07505082
First seen Apr 03, 2026 · Last updated Jun 08, 2026 · Updated 12 times
Summary
This small pilot study is testing whether giving a second treatment with the Nectero EAST system is safe and helpful for people with abdominal aortic aneurysms (a bulging blood vessel in the belly). Ten adults who already had one treatment will get a repeat procedure. The goal is to see if the device can be delivered successfully and if it slows the aneurysm's growth over two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AAA - ABDOMINAL AORTIC ANEURYSM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Auckland City Hospital
RECRUITINGAuckland, 1023, New Zealand
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prince of Wales Private Hospital- POW Vascular Institute
RECRUITINGRandwick, New South Wales, 2031, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.